BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...

In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...

Rhumbline Advisers grew its holdings in MercadoLibre, Inc. (NASDAQ:MELI – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm ...

The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

Investing.com -- BTIG downgraded General Dynamics Corporation (NYSE:GD)to Neutral given the ongoing regulatory hurdles and supply chain disruptions that could hamper growth in 2025. The brokerage ...

Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...

Oncocyte will host one-on-one meetings with interested investors. Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule.

On Monday, BTIG analyst Andrew Harte maintained a Neutral rating on Global Payments Inc. (NYSE:GPN) stock, despite an approximate 11% increase in share value since the company's third-quarter 2024 ...

BTIG Research decreased their Q1 2025 earnings estimates for shares of Meritage Homes in a report issued on Tuesday, February 4th. BTIG Research analyst C. Reichardt now forecasts that the ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday ...